|
|
|
|
LEADER |
00000cam a2200000Ma 4500 |
001 |
EBOOKCENTRAL_ocn888352788 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr |n||||||||| |
008 |
140822s2014 xx ob 001 0 eng d |
040 |
|
|
|a IDEBK
|b eng
|e pn
|c IDEBK
|d EBLCP
|d MHW
|d UKMGB
|d RECBK
|d COO
|d OCLCO
|d OCLCQ
|d ZCU
|d MERUC
|d OCLCQ
|d ICG
|d OCLCQ
|d DKC
|d OCLCQ
|d SGP
|d OCLCO
|d OCLCQ
|d OCLCL
|
016 |
7 |
|
|a 016863759
|2 Uk
|
020 |
|
|
|a 1322060045
|q (ebk)
|
020 |
|
|
|a 9781322060040
|q (ebk)
|
020 |
|
|
|a 9783527336388
|
020 |
|
|
|a 3527336389
|
020 |
|
|
|a 9783527676149
|
020 |
|
|
|a 3527676147
|
020 |
|
|
|a 9783527676156
|
020 |
|
|
|a 3527676155
|
020 |
|
|
|a 9783527676163
|
020 |
|
|
|a 3527676163
|
029 |
1 |
|
|a DEBBG
|b BV044069979
|
035 |
|
|
|a (OCoLC)888352788
|
037 |
|
|
|a 637255
|b MIL
|
050 |
|
4 |
|a RM262 .P384 2014
|
082 |
0 |
4 |
|a 615.329
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Phoenix, David A.
|
245 |
1 |
0 |
|a Novel Antimicrobial Agents and Strategies.
|
260 |
|
|
|b Wiley-VCH,
|c 2014.
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
588 |
0 |
|
|a Print version record.
|
520 |
|
|
|a By integrating knowledge from pharmacology, microbiology, molecular medicine, and engineering, researchers from Europe, the U.S. and Asia cover a broad spectrum of current and potential antimicrobial medications and treatments. The result is a comprehensive survey ranging from small-molecule antibiotics to antimicrobial peptides and their engineered mimetics, from enzymes to nucleic acid therapeutics, from metallic nanoparticles to photo- and sonosensitizers and to phage therapy. In each case, the therapeutic approaches are compared in terms of their mechanisms, likelihood to induce resistance.
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Novel Antimicrobial Agents and Strategies; Contents; List of Contributors; Preface; Chapter 1 The Problem of Microbial Drug Resistance; 1.1 Introduction; 1.2 History of the Origins, Development, and Use of Conventional Antibiotics; 1.3 Problems of Antibiotic Resistance; 1.4 Multiple Drug-Resistant (MDR), Extensively Drug-Resistant (XDR), and Pan-Drug-Resistant (PDR) Organisms; 1.5 MDR Mechanisms of Major Pathogens; 1.6 Antimicrobial Stewardship Programs; 1.7 Discussion; Acknowledgment; References; Chapter 2 Conventional Antibiotics -- Revitalized by New Agents; 2.1 Introduction
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Anti-infective agents
|x Development.
|
650 |
|
6 |
|a Antiinfectieux
|x Développement.
|
758 |
|
|
|i has work:
|a Novel antimicrobial agents and strategies (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCFPhcHHBM4MxJJHG3RmWXd
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|z 9781322060040
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=1767041
|z Texto completo
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL1767041
|
938 |
|
|
|a ProQuest MyiLibrary Digital eBook Collection
|b IDEB
|n cis28863440
|
938 |
|
|
|a Recorded Books, LLC
|b RECE
|n rbeEB00584084
|
994 |
|
|
|a 92
|b IZTAP
|